Health

After a few lackluster years, biotech IPOs have rebounded in 2026. A new record for the most cash raised by a biotech in an IPO was set in April only …

Ladder Health, a virtual-first pediatric developmental care startup, announced on Tuesday that it secured $7 million in seed funding to expand into new markets. Boston-based Ladder Health supports children aged …

New federal attention to psychedelic research and a major Texas-funded clinical trial initiative are moving compounds like ibogaine from the margins of substance use disorder (SUD) treatment debate into a …

Artificial intelligence (AI) is being rapidly adopted throughout the healthcare industry as organizations make more substantial investments in their AI infrastructure, the number of tech-forward pilot programs continues to grow, …

AbbVie is boosting its already strong presence in immunology with the acquisition of Apogee Therapeutics, a clinical-stage biotech whose most advanced drug candidate could bring advantages over several currently available …

A simmering dispute between Eli Lilly and the nation’s hospitals boiled over last week. The drugmaker had been threatening to pull 340B discounts from hospitals that refused to submit claims …

At a time where vaccine skepticism is growing and the childhood vaccine schedule updated in January, vaccine manufacturers are running into a difficult regulatory review process in the United States. …

For decades, employer-sponsored healthcare relied on the same predictable levers to manage spending. Employers rolled out higher deductibles, narrower networks, and increased cost sharing. But a more meaningful shift is …

The case that many startups are making for automating the healthcare revenue cycle is pretty straightforward. Claims follow rules, payers adhere to guidelines, and most of this work is repetitive …

For both the builders and users of clinical AI, bias remains one of the single greatest issues keeping the industry up at night. The prevailing anxiety revolves around one urgent …